Identifying Social Determinants of Health and Allocating Resources During the COVID-19 Pandemic.

Unlabelled: Currently, the world has found itself in a global pandemic with coronavirus. At its start, to limit the spread of this virus, countries, states, and counties have implemented stay-at-home orders and shutdowns. These shutdowns had great impacts on people's well-being and exacerbated social determinants of health.

Depression Before and After a Diagnosis of Pancreatic Cancer: Results From a National, Population-Based Study.

Objectives: The aim of this study was to evaluate depression in pancreatic cancer (PC) patients before and after a cancer diagnosis using a US-based healthcare database. We also sought to study the impact of treatment of depression in PC patients on all-cause mortality.

Methods: Pancreatic cancer patients with comorbid depression in Explorys (1999-2019) were compared with controls using odds ratios with 95% confidence intervals.

Old new: Risk factors predicting early onset colorectal cancer.

Background: Colorectal cancer (CRC) is the second leading cause of all cancer related deaths in the United States and Europe. Although the incidence has been decreasing for individuals' ≥ 50, it has been on the rise for individuals < 50.

Aim: To identify potential risk factors for early-onset CRC.

Defining Pancreatitis as a Risk Factor for Pancreatic Cancer: The Role, Incidence, and Timeline of Development.

Objectives: Acute and/or chronic pancreatitis has been implicated as an important risk factor for pancreatic cancer; however, the incidence and temporal relationship of pancreatitis before pancreatic cancer diagnosis are unclear. We aim to understand the role and incidence of pancreatitis temporally with the development of pancreatic cancer.

Methods: A population-based study was used to investigate a temporal relationship between pancreatitis and pancreatic cancer diagnoses.

A Pilot Study of the Effect of an Educational Web Application on Asthma Control and Medication Adherence.

Background: An Asthma Adherence Pathway (AAP) application, which is an Internet application that combines patient and clinician education strategies to promote adherence to asthma therapy, has been developed.

Objective: The primary objective of this pilot study was to evaluate the effectiveness of the AAP application with electronic adherence monitors on asthma control. Secondary objectives evaluated the effect of AAP and monitors on medication adherence, asthma symptoms, quality of life, psychosocial factors, and barriers to treatment.

Fluoroscopy Dose and Time Characteristics During Endoscopic Retrograde Cholangiopancreatography (ERCP).

Radiation exposure during endoscopic retrograde cholangiopancreatography is known, however, data in relation to radiation usage is unclear. We evaluate radiation exposure using fluoroscopy dose (FD) and time (FT). A prospective analysis of 197 patients undergoing endoscopic retrograde cholangiopancreatography was completed.

Ocular Radiation Threshold Projection Based off of Fluoroscopy Time During ERCP.

Objectives: Current international guidelines for ocular radiation exposure suggest a threshold of 20 millisieverts (mSv)/year. Although endoscopists wear lead aprons, use of protective eye wear is optional. This study was conducted to analyze the lens radiation exposure during endoscopic retrograde cholangiopancreatography (ERCP) for endoscopists to determine the time of fluoroscopy needed to warrant using lens protection during ERCP.

A retrospective chart review evaluating the association of psychological disorders and vitamin D deficiency with celiac disease.

Background: Data show that deficiencies in Vitamin D have been linked to certain psychological disorders and celiac disease. This study was designed to evaluate the association of psychological comorbidities and vitamin D deficiency with celiac disease. Additionally, any association of psychological comorbidities with gender and age at diagnosis with celiac disease was evaluated.

Diabetic Ketoacidosis With Canagliflozin, a Sodium-Glucose Cotransporter 2 Inhibitor, in Patients With Type 1 Diabetes.

Objective: To assess the incidence of serious adverse events (AEs) of diabetic ketoacidosis (DKA) with canagliflozin, a sodium-glucose cotransporter 2 inhibitor, as an add-on to insulin in adults with type 1 diabetes.

Research Design And Methods: In this 18-week, randomized, double-blind, phase 2 study, patients (N = 351; HbA1c 7.0-9.

Efficacy and Safety of Canagliflozin, a Sodium-Glucose Cotransporter 2 Inhibitor, as Add-on to Insulin in Patients With Type 1 Diabetes.

Objective: This study assessed the efficacy and safety of canagliflozin, a sodium-glucose cotransporter 2 inhibitor, as add-on to insulin in adults with type 1 diabetes.

Research Design And Methods: This 18-week, double-blind, phase 2 study randomized 351 patients (HbA1c 7.0-9.